Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a...
Month: May 2021
Chiesi Group calls for #ActionOverWords in the fight against climate change
Chiesi Group, the largest international pharmaceutical company Certified B Corporation™, reinforces 2035 carbon neutral target with #ActionOverWords campaign to encourage...
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease
VAX-24 is a 24-Valent Broad-Spectrum Pneumococcal Conjugate Vaccine Leveraging Vaxcyte’s Technology PlatformFOSTER CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) --...
RVL Pharmaceuticals Upneeq® Wins 2021 MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and CompaniesBRIDGEWATER, N.J., May 10, 2021 (GLOBE NEWSWIRE) -- RVL...
INDUSTRY SOURCE CONSULTING PROVIDES MARKET REPORTS AS IT MOVES FORWARD WITH NEW BUSINESS STRATEGY
Thomasville, GA, May 10, 2021 (GLOBE NEWSWIRE) -- Industry Source Consulting, Inc. (OTC: INSO), reported today that it has submitted...
BioCorRx Receives FDA Clearance of Investigational New Drug (IND) Application for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and...
BioVie Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix
SANTA MONICA, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing...
BeyondSpring to Present at the Bank of America Securities 2021 Health Care Conference on May 13, 2021
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (“BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the...
Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders
REDWOOD CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies Inc. (“Adverum”) (Nasdaq: ADVM), a clinical-stage gene therapy company...
Aeterna Zentaris to Present at the Q2 Virtual Investor Summit
– Live video webcast with CEO, Dr. Klaus Paulini, on Monday, May 17, 2021 at 8:45 AM ET CHARLESTON, S.C.,...
Saniona Launches New Video Series to Highlight the Impact of Prader-Willi Syndrome and Hypothalamic Obesity on Patients and Caregivers
PRESS RELEASE May 10, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced its...
CENTR Brands Corp. Signs Tennessee Distribution Agreement with Lipman Brothers
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Global Smart Hospitals Market to Surpass US$ 105,245.0 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE--(BUSINESS WIRE)--#SmartHospitals--According to Coherent Market Insights, the global Smart Hospitals market is estimated to be valued at US$ 28,200.1 million...
MANA Therapeutics Appoints Arthur Hurwitz as Chief Scientific Officer
Michael Kuo appointed as Senior Vice President of Technical Operations WALTHAM, Mass.--(BUSINESS WIRE)--MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf...
Surescripts Leads Industry Transformation to NCPDP’s SCRIPT Standard v2017071 to Strengthen Patient Safety and Improve Workflow Efficiency
EHRs and Pharmacies Must Take Action Now to Minimize Disruption for Patients and Providers Ahead of September 1, 2021 Sunset...
Intersect ENT Reports First Quarter 2021 Financial Results
— Increases 2021 Revenue Guidance to $117 Million to $121 Million — MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT),...
Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product
VANCOUVER, BC / ACCESSWIRE / May 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF,...
Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality
Researchers Found That O3 May Help Clinicians Rapidly Assess Circulatory Status in Patients Experiencing Septic Shock and Have Prognostic Value...
Integrative Providers Association Celebrates Nurses Week With Honors
WASHINGTON, DC / ACCESSWIRE / May 8, 2021 / Integrative Providers Association (IPA) wishes all nurses a Happy Nurses Week...
Avicanna Announces Resignation of Board Member
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...